NEW YORK, Dec. 26, 2023 /PRNewswire/ — The AllianceBernstein Closed-End Funds declared the following distributions today: FUND NAME AND DISTRIBUTIONS EX-DATE RECORD DATE PAYMENT DATE AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF) 01/04/2024 01/05/2024 01/19/2024 $0.0655 per share of investment income AllianceBernstein National Municipal Income Fund, Inc. (NYSE: AFB) 01/04/2024 01/05/2024 01/19/2024 $0.03266 per… Continue reading ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
Category: Newswire
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
NEW YORK, Dec. 26, 2023 /PRNewswire/ — AllianceBernstein National Municipal Income Fund, Inc.[NYSE: AFB] (the “Fund”) today released its monthly portfolio update as of November 30, 2023. AllianceBernstein National Municipal Income Fund, Inc. Top 10 Fixed-Income Holdings Portfolio % 1) City of New Orleans LA Series 2021-A 5.00%, 12/01/46 2.71 % 2) Melissa Independent School District Series… Continue reading AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
AllianceBernstein Global High Income Fund, Inc. Top 10 Fixed-Income Holdings Portfolio % 1) U.S. Treasury Notes 2.25%, 02/15/27 1.09 % 2) CCO Holdings 4.50%, 08/15/30 – 06/01/33 0.68 % 3) CCO Holdings 4.75%, 02/01/32 0.64 % 4) Dominican Republic Intl Bond 8.625%, 04/20/27 0.64 % 5) Sirius XM Radio, Inc. 4.00%, 07/15/28 0.59 % 6) Royal Caribbean Cruises 5.50%, 08/31/26… Continue reading AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
SomaLogic Publishes Key Correspondence from LabCorp CEO Omitted by Madryn in its Attempt to Undermine Confidence in SomaLogic’s Thorough Strategic Process Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders BOULDER, Colo., Dec. 26, 2023 /PRNewswire/ — SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in… Continue reading SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit
LOS ANGELES, Dec. 26, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN). Class Period: May 1, 2023 – October 16, 2023 Lead Plaintiff Deadline: January 9, 2024 If you… Continue reading ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit
SMR Investors Have Opportunity to Lead NuScale Power Corporation Securities Fraud Lawsuit
LOS ANGELES, Dec. 26, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR). Class Period: March 15, 2023 – November 8, 2023 Lead Plaintiff Deadline: January 16, 2024… Continue reading SMR Investors Have Opportunity to Lead NuScale Power Corporation Securities Fraud Lawsuit
CHPT Investors Have Opportunity to Lead ChargePoint Holdings, Inc. Securities Fraud Lawsuit
LOS ANGELES, Dec. 26, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”) (NYSE: CHPT). Class Period: June 1, 2023 – November 16, 2023 Lead Plaintiff Deadline: January 29, 2024… Continue reading CHPT Investors Have Opportunity to Lead ChargePoint Holdings, Inc. Securities Fraud Lawsuit
EGRX Investors Have Opportunity to Lead Eagle Pharmaceuticals, Inc. Securities Fraud Lawsuit
LOS ANGELES, Dec. 26, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX). Class Period: August 8, 2023 – November 28, 2023 Lead Plaintiff Deadline: February 9,… Continue reading EGRX Investors Have Opportunity to Lead Eagle Pharmaceuticals, Inc. Securities Fraud Lawsuit
LICY Investors Have Opportunity to Lead Li-Cycle Holdings Corp. Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 26, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Li-Cycle Holdings Corp. (“Li-Cycle” or the “Company”) (NYSE: LICY). Class Period: June 14, 2022 – October 23, 2023 Lead Plaintiff Deadline: January 8, 2024 Investors suffering… Continue reading LICY Investors Have Opportunity to Lead Li-Cycle Holdings Corp. Securities Fraud Lawsuit
PAYC Investors Have Opportunity to Lead Paycom Software, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 26, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Paycom Software, Inc. (“Paycom” or the “Company”) (NYSE: PAYC). Class Period: May 3, 2023 – November 1, 2023 Lead Plaintiff Deadline: January 9, 2024 Investors suffering… Continue reading PAYC Investors Have Opportunity to Lead Paycom Software, Inc. Securities Fraud Lawsuit